Drug Enforcement D-0651-2024

Lack of Assurance of Sterility

Status

Ongoing

Classification

Class II

Report Date

September 11, 2024

Termination Date

—

Product Information

Product description
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
Product quantity
37 vials
Reason for recall
Lack of Assurance of Sterility
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA

Location & Firm

Recalling firm
ProRx LLC
Address
619 Jeffers Cir

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0651-2024
Event ID
95190
Recall initiation date
August 22, 2024
Center classification date
September 5, 2024
Code info
Lot # ProRx040924-1, BUD 10/08/2024
More code info
—